Downregulation of Fas ligand (FasL, CD95L) expression on T cells: A novel mechanism for preventing spontaneous and adoptive transfer of IDDM

被引：0
|
作者：
Singh, B
Zechel, M
Chaturvedi, P
Qin, HY
机构：
来源：
DIABETES | 1998年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
859
引用
收藏
页码：A222 / A222
页数：1
相关论文
共 50 条
  • [1] Fas ligand (FasL, CD95L, APO-1L) expression in murine mast cells
    Wagelie-Steffen, AL
    Hartmann, K
    Vliagoftis, H
    Metcalfe, DD
    IMMUNOLOGY, 1998, 94 (04) : 569 - 574
  • [2] Tumor expression of Fas ligand (CD95L) and the consequences
    Walker, PR
    Saas, P
    Dietrich, PY
    CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (05) : 564 - 572
  • [3] Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L)
    Winter, H
    Hu, HM
    Urba, WJ
    Fox, BA
    JOURNAL OF IMMUNOLOGY, 1999, 163 (08): : 4462 - 4472
  • [4] Functional Fas ligand (FasL, CD95L) expression on primary human keratinocytes is modulated by different cytokines
    Arnold, R
    Seifert, M
    Volk, HD
    Asadullah, K
    10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2, 1998, : 663 - 667
  • [5] Resistance to Gemcitabine (OEM) in a Fas-ligand (FasL)-resistant cell line is not dependent on the Fas/Fasl (CD95/CD95L) system
    Meli, M
    Tolomeo, M
    D'Alessandro, N
    Grimaudo, S
    Ruberti, G
    Papoff, G
    Rausa, L
    Dusonchet, L
    ANNALS OF ONCOLOGY, 1998, 9 : 133 - 133
  • [6] A Novel Tetravalent CD95/Fas Fusion Protein With Superior CD95L/FasL Antagonism
    Lang, Isabell
    Paulus, Oliver
    Zaitseva, Olena
    Wajant, Harald
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2025, 93 (02) : 441 - 451
  • [7] Enhanced expression of Fas ligand (CD95L) on T cells after segmental allergen provocation in asthma
    Krug, N
    Tschernig, T
    Balke, K
    Erpenbeck, VJ
    Meyer, L
    Bode, U
    Hohlfeld, JM
    Pabst, R
    Fabel, H
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (04) : 649 - 655
  • [8] Immunohistochemical characterization of Fas (CD95) and Fas Ligand (FasL/CD95L) expression in the injured brain: Relationship with neuronal cell death and inflammatory mediators
    Grosjean, M. B.
    Lenzlinger, P. M.
    Stahel, P. F.
    Yatsiv, I.
    Shohami, E.
    Trentz, O.
    Kossmann, T.
    Morganti-Kossmann, M. C.
    HISTOLOGY AND HISTOPATHOLOGY, 2007, 22 (03) : 235 - 250
  • [9] Upregulation of Fas/FasL (CD95/CD95L)-mediated epithelial apoptosis: a novel therapeutic target in pouchitis
    Coffey, JC
    Bennett, MW
    Wang, JH
    Neary, P
    O'Connell, J
    Shanahan, F
    Redmond, HP
    Kirwan, WO
    BRITISH JOURNAL OF SURGERY, 2001, 88 (05) : 756 - 756
  • [10] Metabolic disruption as a mechanism for inducing susceptiflity to fas (CD95): FasL (CD95L) mediated tumor cell death
    Newell, M. Karen
    Das, Stuti
    Rogers, Susannah Kathleen
    Villalobos-Menuey, Elizabeth
    FREE RADICAL BIOLOGY AND MEDICINE, 2007, 43 : S52 - S53
12345